COMMUNIQUÉS West-GlobeNewswire

-
Bone Therapeutics SA: Information on the total number of voting rights and shares
29/05/2019 -
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
29/05/2019 -
HEXO Corp. announces acquisition of Securities of Newstrike Brands Ltd.
28/05/2019 -
HEXO Corp annonce l’acquisition des titres de Newstrike Brands Ltd.
28/05/2019 -
Atara Biotherapeutics Appoints Pascal Touchon President, Chief Executive Officer and Member of the Board of Directors
28/05/2019 -
R1 to Present at the Jefferies 2019 Healthcare Conference
28/05/2019 -
Autolus Therapeutics to Participate in Upcoming Investor Conferences in June
28/05/2019 -
MediPharm Labs Announces $60 Million Bought Deal Equity Financing
28/05/2019 -
Genmab Files Registration Statement in the United States for a Proposed Public Offering of American Depositary Shares (ADSs) and Applies for Listing of the ADSs on Nasdaq
28/05/2019 -
miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference
28/05/2019 -
MacroGenics to Host Conference Call and Webcast to Review Margetuximab Phase 3 SOPHIA Study Presentation at ASCO
28/05/2019 -
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
28/05/2019 -
Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019 -
Tonix Pharmaceuticals to Present at BIO 2019 International Convention
28/05/2019 -
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
28/05/2019 -
Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-Cell Receptors Targeting Neoantigens for Cancer with Sleeping Beauty Platform
28/05/2019 -
Rexahn Announces Move to Nasdaq
28/05/2019 -
Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
28/05/2019 -
Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market
28/05/2019
Pages